Ocugen logo

Ocugen

OCGN | NASDAQ
Chart Builder DCF Calculator
$0.77
-$0.06 (-6.98%)
At close: Nov 16, 2026, 4:00 PM ET
$0.77
$0.00 (+0.48%)
After-hours: Nov 16, 2026, 7:54 PM ET
-6.98%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
43
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #445/1021 (Top 44%)

Key Statistics

Market Data

Market Cap $262.28M
1D Range
0.74 0.82
52W Range
0.70 2.48

Valuation (TTM)

PE -3.85
PB -14.83
EV/EBITDA -3.83

Valuation (NTM)

Forward PE 431.57
Forward PEG 0.33
Price Target $5.00
Loading financial charts...

Profile

Ocugen, Inc. is a biopharmaceutical company in the clinical development phase, primarily dedicated to pioneering gene therapies aimed at treating various ophthalmic conditions leading to blindness. Th...

Sector Healthcare
Industry Biotechnology
Employees 116
IPO Date Dec 3, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 4, 2026
EPS
-$0.06
Beat 0.00%
REV
$1.95M
Beat +48.07%
Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$5.00
Upside
+549.35%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.